期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Distributed Economic MPC for Synergetic Regulation of the Voltage of an Island DC Micro-Grid
1
作者 Yi Zheng yanye wang +2 位作者 Xun Meng Shaoyuan Li Hao Chen 《IEEE/CAA Journal of Automatica Sinica》 SCIE EI CSCD 2024年第3期734-745,共12页
In this paper,distributed model predictive control(DMPC) for island DC micro-grids(MG) with wind/photovoltaic(PV)/battery power is proposed,which coordinates all distributed generations(DG) to stabilize the bus voltag... In this paper,distributed model predictive control(DMPC) for island DC micro-grids(MG) with wind/photovoltaic(PV)/battery power is proposed,which coordinates all distributed generations(DG) to stabilize the bus voltage together with the insurance of having computational efficiency under a real-time requirement.Based on the feedback of the bus voltage,the deviation of the current is dispatched to each DG according to cost over the prediction horizon.Moreover,to avoid the excessive fluctuation of the battery power,both the discharge-charge switching times and costs are considered in the model predictive control(MPC) optimization problems.A Lyapunov constraint with a time-varying steady-state is designed in each local MPC to guarantee the stabilization of the entire system.The voltage stabilization of the MG is achieved by this strategy with the cooperation of DGs.The numeric results of applying the proposed method to a MG of the Shanghai Power Supply Company shows the effectiveness of the distributed economic MPC. 展开更多
关键词 Distributed model predictive control(DMPC) Lyapunovbased model predictive control micro-grid(MG) voltage control
下载PDF
非小细胞肺癌新辅助靶向及免疫治疗研究进展和展望 被引量:37
2
作者 徐嵩 赵世康 +4 位作者 任凡 任典 王延烨 宋作庆 陈军 《中国肿瘤临床》 CAS CSCD 北大核心 2020年第6期299-303,共5页
肺癌是全球发病率和死亡率最高的恶性肿瘤。近年来,随着新型药物的出现和治疗模式的优化,肺癌患者的预后已有一定改善。新辅助治疗是指对潜在可接受手术切除的患者,先给予术前抗肿瘤治疗后再行手术治疗。新辅助治疗通过术前治疗可以缩... 肺癌是全球发病率和死亡率最高的恶性肿瘤。近年来,随着新型药物的出现和治疗模式的优化,肺癌患者的预后已有一定改善。新辅助治疗是指对潜在可接受手术切除的患者,先给予术前抗肿瘤治疗后再行手术治疗。新辅助治疗通过术前治疗可以缩小肿瘤体积,降低肿瘤分期;并且可以杀灭患者机体中循环肿瘤细胞及微转移病灶,令患者远期生存获益。靶向治疗及免疫治疗已被应用于晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)的一线治疗。因此,有临床试验尝试将以上两种治疗手段应用于早期可切除NSCLC患者的新辅助治疗。本文针对新辅助靶向及免疫治疗对早期可切除NSCLC患者的疗效、治疗中的潜在风险予以综述,并探讨新辅助治疗的未来发展方向。 展开更多
关键词 非小细胞肺癌 新辅助治疗 靶向治疗 免疫治疗
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部